CN105878236B - To application of the N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of anti-Staphylococcus aureus - Google Patents

To application of the N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of anti-Staphylococcus aureus Download PDF

Info

Publication number
CN105878236B
CN105878236B CN201610243365.6A CN201610243365A CN105878236B CN 105878236 B CN105878236 B CN 105878236B CN 201610243365 A CN201610243365 A CN 201610243365A CN 105878236 B CN105878236 B CN 105878236B
Authority
CN
China
Prior art keywords
aminotoluene
schiff bases
staphylococcus aureus
ortho
benzaldehyde contracting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610243365.6A
Other languages
Chinese (zh)
Other versions
CN105878236A (en
Inventor
冯小军
苏成柏
戴必胜
郑正
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingyuan Polytechnic
Original Assignee
Qingyuan Polytechnic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingyuan Polytechnic filed Critical Qingyuan Polytechnic
Priority to CN201610243365.6A priority Critical patent/CN105878236B/en
Publication of CN105878236A publication Critical patent/CN105878236A/en
Application granted granted Critical
Publication of CN105878236B publication Critical patent/CN105878236B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Abstract

The invention discloses the applications to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of anti-Staphylococcus aureus.The structural formula such as following formula to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases(I)It is shown:.The compound has a good antibacterial activity, and nearly to the inhibiting rate of staphylococcus aureus 100%, and the preparation method of the compound is simple, at low cost, is highly suitable for mass producing.Therefore, preparation method of the invention and its antimicrobial compound that is prepared, in particular for staphylococcus aureus, have good application prospect to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of antibacterial and prepare inhibiting-bacteria preparation.

Description

To N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of anti-Staphylococcus aureus Application
Technical field
The invention belongs to compound technicals.Exist more particularly, to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases Application in terms of anti-Staphylococcus aureus.
Background technology
Schiff bases is primarily referred to as containing imines or azomethine characteristic group(-RC=N-)A kind of organic compound, it is usually uncommon Husband's alkali is condensed by amine and active carbonyl group.
Schiff bases compound and its metal complex are in medicine, catalysis, analytical chemistry, corrosion and photochromic field Important application.In medical domain, schiff bases has antibacterial, sterilization, antitumor, antiviral bioactivity;In catalytic field, The cobalt and nickel complex of schiff bases have been used as catalyst to use;In analysis field, schiff bases is as good ligand, Ke Yiyong Differentiate, identifies the content of metal ion and quantitative analysis metal ion;In corrosion field, certain aromatic schiff bases are frequent Corrosion inhibiter as copper;In photochromic field, certain schiff bases containing characteristic group also have unique application.Therefore, There are the largely study on the synthesis about Schiff bases compound and property research.
Invention content
The object of the present invention is to provide a kind of new Schiff bases compounds, i.e., uncommon to N imidazoles benzaldehyde contracting ortho-aminotoluenes Husband's alkali, the application in terms of anti-Staphylococcus aureus.
Another object of the present invention is to provide the above-mentioned preparation method to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases.
Above-mentioned purpose of the present invention is achieved through the following technical solutions:
The invention discloses to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases answering in terms of anti-Staphylococcus aureus With.
The structural formula such as following formula to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases(I)It is shown:
It is above-mentioned to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases answering in terms of the preparation for preparing anti-Staphylococcus aureus With also within protection scope of the present invention.
In addition, the above-mentioned preparation method to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases is:
In absolute ethyl alcohol, N imidazolyl benzaldehydes and ortho-aminotoluene will be mixed, stirring, be placed 20~35 days under room temperature Afterwards, faint yellow bulk crystals are precipitated.
Preferably, above-mentioned preparation method is:N imidazolyl benzaldehydes and ortho-aminotoluene will be dissolved in absolute ethyl alcohol respectively, Two parts of solution are mixed again, stirring, after being placed 20~35 days under room temperature, there are faint yellow bulk crystals to be precipitated;Wherein, described to N The ratio between amount of substance of imidazolyl benzaldehyde and ortho-aminotoluene is 1:1~2(The two heats after mixing in ethanol, then cannot get The product).
It is further preferred that after there are faint yellow bulk crystals to be precipitated, dried on filter paper after being then sucked out with rubber head dropper.
Preparation method of the present invention obtains the yield of product 96% or more.
Wherein it is preferred to which the room temperature refers to 15~25 DEG C.
Preferably, the amount ratio of the substance to N imidazolyl benzaldehydes and ortho-aminotoluene is 1:1.
Preferably, it is placed 15~40 days under the room temperature.
It is highly preferred that being placed 20~35 days under the room temperature.
It is highly preferred that being placed 25~30 days under the room temperature.
Most preferably, it is placed 28 days under the room temperature.
The invention has the advantages that:
The present invention provides a kind of new antimicrobial compounds to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases, the compound With good antibacterial activity, nearly to the inhibiting rate of staphylococcus aureus 100%.
Moreover, the preparation method of the compound is simple, at low cost, it is highly suitable for mass producing.Therefore, of the invention Preparation method and its antimicrobial compound that is prepared are to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases antibacterial and prepare antibacterial There is good application prospect in terms of preparation.
Description of the drawings
Fig. 1 is the mono-crystalline structures to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases.
Fig. 2 is the nuclear magnetic spectrum to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases(It is whole).
Fig. 3 is the nuclear magnetic spectrum to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases(Part).
Fig. 4 is to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases to the inhibiting effect of staphylococcus aureus.
Specific implementation mode
It is further illustrated the present invention below in conjunction with Figure of description and specific embodiment, but embodiment is not to the present invention It limits in any form.Unless stated otherwise, the present invention uses reagent, method and apparatus routinely try for the art Agent, method and apparatus.
Unless stated otherwise, following embodiment agents useful for same and material are purchased in market.
Preparation of the embodiment 1 to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases
It 1, respectively will be to N imidazolyl benzaldehydes and ortho-aminotoluene according to 1:The amount of 1 substance than being dissolved in anhydrous second respectively In alcohol, two parts of solution are mixed, stirring, after being placed 28 days under room temperature, there are faint yellow bulk crystals to be precipitated(The two is mixed in ethanol It is heated after conjunction, then cannot get the product), yield is 96% or more.Then it is dried on filter paper after being sucked out with rubber head dropper.
Wherein, the room temperature refers to 15~25 DEG C.
2, the above-mentioned product being prepared is identified.The structural formula of the compound such as following formula(I)It is shown:
The mono-crystalline structures of the compound are as shown in Fig. 1.
Crystal parameter is respectively:P2 (1)/n crystallographic systems, a=13.0657, b=8.2103, c=14.0414;α=90.000, β= 111.788 γ=90.000;r=0.0437.
The nuclear magnetic spectrum of the compound is as shown in Fig. 2 and 3.
Fig. 2 is its HNMR spectrogram(It is whole), Fig. 3 is its Local map.It is-CH in molecular structure at δ 2.413(Hydrogen)It is unimodal, At 8.435 in-CH=N- 1 hydrogen atom it is unimodal, 7.0-8.2 at, 11 hydrogen atom peaks are shared, for two phenyl ring and 1 miaow Corresponding 11 hydrogen atoms in azoles ring.
Antibacterial activity in vitro research of the embodiment 2 to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases
1, product prepared by embodiment(Crystal)It is first cleaned with ethyl alcohol, dries grind into powder and pour into sample cell, use CH2Cl2 Dissolving, then the scraps of paper to have sterilized are put into sample cell(Circle, diameter 0.5cm)Adsorption sample solution, by the scraps of paper of carry sample Taking-up is dried, and is put into the agar medium of staphylococcus aureus, is cultivated 24 hours at 5 groups, 37 DEG C of Duplicate Samples, rear observation suppression Bacterium circle.
In addition, the scraps of paper are put into absolute ethyl alcohol, CH is placed into after drying2Cl2In, taking-up is dried as blank control, does 5 Group blank control.
2, result is as shown in Fig. 4, and apparent inhibition zone occurs in experimental group, and blank control does not find inhibition zone, table Bright provided by the invention have apparent bacteriostatic activity to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases to staphylococcus aureus.
In addition, larger to the inhibition zone of staphylococcus aureus to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases hand over obviously, And the not growth of bacterium completely in inhibition zone, the compound nearly to the inhibiting rate of staphylococcus aureus 100%.

Claims (2)

1. pair application of the N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of the preparation for preparing anti-Staphylococcus aureus, It is characterized in that, the structural formula such as following formula to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases(I)It is shown:
2. a kind of antiseptic of anti-Staphylococcus aureus, which is characterized in that containing described in claim 1 to N imidazoles benzene first Aldehyde contracting ortho-aminotoluene schiff bases.
CN201610243365.6A 2016-04-19 2016-04-19 To application of the N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of anti-Staphylococcus aureus Active CN105878236B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610243365.6A CN105878236B (en) 2016-04-19 2016-04-19 To application of the N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of anti-Staphylococcus aureus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610243365.6A CN105878236B (en) 2016-04-19 2016-04-19 To application of the N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of anti-Staphylococcus aureus

Publications (2)

Publication Number Publication Date
CN105878236A CN105878236A (en) 2016-08-24
CN105878236B true CN105878236B (en) 2018-10-26

Family

ID=56704037

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610243365.6A Active CN105878236B (en) 2016-04-19 2016-04-19 To application of the N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of anti-Staphylococcus aureus

Country Status (1)

Country Link
CN (1) CN105878236B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656624A (en) * 1994-12-21 1997-08-12 Schering Corporation 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
CN103156844A (en) * 2011-12-15 2013-06-19 天津市国际生物医药联合研究院 Application of Schiff base compound in inhibition of activity of NDM-1

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656624A (en) * 1994-12-21 1997-08-12 Schering Corporation 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
CN103156844A (en) * 2011-12-15 2013-06-19 天津市国际生物医药联合研究院 Application of Schiff base compound in inhibition of activity of NDM-1

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Synthesis and antimicrobial evaluation of novel N-(4-(pyrrolidin-1-yl)benzylidene)-arylamine and diethyl(arylamino)(4-(pyrrolidin-1-yl)phenyl)methyl phosphonate;Sandeep D. Pardeshi, et al.;《Heterocyclic Letters》;20151231;第5卷(第1期);第97-104页,尤其是第101页表1和103页表4 *
新型抗菌药物咪唑类化合物研究;袁勇等;《第四届全国化学生物学学术会议暨国际化学与生物/医学交叉研讨会》;20051031;第201页,尤其是第201页第1段第3-4行 *

Also Published As

Publication number Publication date
CN105878236A (en) 2016-08-24

Similar Documents

Publication Publication Date Title
Rosu et al. Synthesis, characterization and antibacterial activity of some new complexes of Cu (II), Ni (II), VO (II), Mn (II) with Schiff base derived from 4-amino-2, 3-dimethyl-1-phenyl-3-pyrazolin-5-one
Singh et al. Cobalt, nickel, copper and zinc complexes with 1, 3-diphenyl-1H-pyrazole-4-carboxaldehyde Schiff bases: Antimicrobial, spectroscopic, thermal and fluorescence studies
Olar et al. Prospects for new antimicrobials based on N, N-dimethylbiguanide complexes as effective agents on both planktonic and adhered microbial strains
Florio et al. Comparative evaluation of antimicrobial activity of different types of ionic liquids
Husain et al. Anagostic interactions, revisiting the crystal structure of nickel dithiocarbamate complex and its antibacterial and antifungal studies
Özdemir et al. Synthesis and antimicrobial activity of Ag (I)‐N‐heterocyclic carbene complexes derived from benzimidazol‐2‐ylidene
Feder-Kubis et al. The effect of the cationic structures of chiral ionic liquids on their antimicrobial activities
Naeimi et al. Synthesis, characterization and in vitro antimicrobial activity of some new Schiff bases and their complexes
Hassan et al. Anti‐hepatocellular carcinoma, antioxidant, anti‐inflammation and antimicrobial investigation of some novel first and second transition metal complexes
Özgeriş Design, synthesis, characterization, and biological evaluation of nicotinoyl thioureas as antimicrobial and antioxidant agents
Bandyopadhyay et al. Synthesis, structure, spectral characterization, electrochemistry and evaluation of antibacterial potentiality of a novel oxime-based palladium (II) compound
Zhao et al. Copper-based metal coordination complexes with Voriconazole ligand: syntheses, structures and antimicrobial properties
Andrejević et al. Synthesis, structural characterization and antimicrobial activity of silver (I) complexes with 1-benzyl-1H-tetrazoles
Jiang et al. Synthesis, characterization and antibacterial activity of a biocompatible silver complex based on 2, 2′-bipyridine and 5-sulfoisophthalate
Hajibabaei et al. Synthesis, characterization and antibacterial activity of imidazole-functionalized Ag/MIL-101 (Cr)
Sahu et al. Synthesis and evaluation of antimicrobial activity of 2-aminobenzothiazolomethyl naphthol derivatives
Sumrra et al. Complexes of imino-1, 2, 4-triazole derivative with transition metals: synthesis and antibacterial study
CN105859628B (en) A kind of antimicrobial compound is to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases and its preparation method and application
Ibrahim et al. Physicochemical studies and biological evaluation on (E)-3-(2-(1-(2-hydroxyphenyl) hydrazinyl)-3-oxo-N-(thiazol-2yl) propanamide complexes
CN105878236B (en) To application of the N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of anti-Staphylococcus aureus
CN102911191B (en) Preparation method for ethanol 2-hydroxyl naphthaldehyde thiosemicarbazone o-phenanthroline metal complex
CN105878235B (en) To application of the N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases in terms of anti-salmonella
Alyar et al. Synthesis, characterization, and antimicrobial activity of copper (II) complexes with N, N′-propanediyl-bis-benzenesulfonamide and N, N′-ethanediyl-bis-2-methylbenzenesulfonamide
Deivanayagam et al. Synthesis, characterization, antimicrobial, analgesic and CNS studies of Schiff base Cu (II) complex derived from 4-choro-o-phenylene Diamine
Yiase et al. Manganese (II) and cobalt (II) acetylacetonates as antimicrobial agents

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant